Learn More
Medchemexpress LLC Gamitrinib TPP hexafluorophosphate | 1131626-47-5 | MFCD31715433 | 99.7% | 1036.03 | C52H65F6N3O8P2 | 25 MG

Supplier: Medchemexpress LLC HY102007A25MG
Gamitrinib TPP hexafluorophosphate is a mitochondria-targeted HSP90 inhibitor that selectively accumulates in the mitochondrial matrix and interferes with mitochondrial Hsp90 function, showing anticancer activity in preclinical studies. It couples an Hsp90 ATPase inhibitory module with a triphenylphosphonium mitochondrial-targeting moiety and is supplied for laboratory research use.
- Mitochondria-targeted HSP90 inhibitor with anticancer activity.
- Selective accumulation in the mitochondrial matrix for targeted action.
- High purity suitable for research applications (≈99.7%).
- Supplied as a solid; soluble in DMSO for biological assays.
- Chemical formula C52H65F6N3O8P2; molecular weight 1036.03.
- Intended for research use only; not for human or veterinary use.
- Packaged in a 25 mg quantity for small-scale experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.